Vanesa Nozal

Years Active: 2020-2021
Publications (10 Years): 5

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS

Universidad Complutense de Madrid (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS Feb 01 2017

Spain

PhD student :: CENTRO DE INVESTIGACIONES BIOLÓGICAS

Education History

Universidad Complutense de Madrid

Spain

MSC :: Organic Chemistry

Publications

Tiziana Ginex, Urtzi Garaigorta, David Ramírez, Victoria Castro, Vanesa Nozal, Ines Maestro, Javier Garcia-Carceles, Nuria E Campillo, Ana Martinez, Pablo Gastaminza, Carmen Gil
Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods. Pharmaceuticals (Basel, Switzerland) 14 (4) (2021)
Elisa Rojas-Prats, Carlota Tosat-Bitrián, Loreto Martínez-González, Vanesa Nozal, Daniel I Pérez, Ana Martinez
Increasing Brain Permeability of PHA-767491, a Cell Division Cycle 7 Kinase Inhibitor, with Biodegradable Polymeric Nanoparticles. Pharmaceutics 13 (2) (2021)
Vanesa Nozal, Elisa Rojas-Prats, Inés Maestro, Carmen Gil, Daniel I Perez, Ana Martinez
Improved Controlled Release and Brain Penetration of the Small Molecule S14 Using PLGA Nanoparticles. International journal of molecular sciences 22 (6) (2021)
Valle Palomo, Vanesa Nozal, Elisa Rojas-Prats, Carmen Gil, Ana Martinez
Protein kinase inhibitors for amyotrophic lateral sclerosis therapy. British journal of pharmacology 178 (6) (2020)
Carmen Gil, Tiziana Ginex, Ines Maestro, Vanesa Nozal, Lucía Barrado-Gil, Miguel Ángel Cuesta-Geijo, Jesús Urquiza, David Ramírez, Covadonga Alonso, Nuria Eugenia Campillo, Ana Martinez
COVID-19: Drug Targets and Potential Treatments. Journal of medicinal chemistry 63 (21) (2020)

Vanesa Nozal.css-eqlu8i{font-size:small;padding-left:4px;}